And I actually love that you're saying that because there's so few even great functional doctors that say, you know, the number one studied intervention is exercise and movement
Alivernini, S
While the share of ESI enrollees with a GLP-1 drug claim has been increasing, still only a relatively modest number of people have a claim Since 2012, the share of non-elderly adults with ESI that have a GLP-1 drug claim has grown more than eightfold (717.7% increase)
Is Pomegranate Health GLP-1 the same as Wegovy, Ozempic, Mounjaro, or Zepbound
The dual agonist mechanism provides robust glycemic control and significant weight reduction, with clinical trials demonstrating A1C reductions of 1.92.4% and weight loss of approximately 1522% of body weight in non-diabetic adults with obesity (SURMOUNT-1 trial), with more modest weight loss typically observed in patients with type 2 diabetes
Esto se debe a que favorece la quema de grasas, aunque esto va de la mano con la prctica de actividad fsica y una alimentacin saludable